Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2016
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
F Trillsch, S Mahner, F Hilpert, et al.
Journal of Geriatric Oncology
|
November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer
Chantal Quinten, C Kenis, M Hamaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2014
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
H Bonnefoi, W Jacot, M Saghatchian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 13, 2018
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
M Ignatiadis, S Litière, F Rothe, et al.
Gynecologic Oncology
|
October 6, 2020
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study
Jorne Ubachs, Simone N Koole, Max Lahaye, et al.
ESMO Open
|
September 2, 2023
Young oncologists' perspective on the role and future of the clinician-scientist in oncology
K H J Lim, C B Westphalen, A S Berghoff, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2016
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial
F Trillsch, S Mahner, F Hilpert, et al.
Journal of Geriatric Oncology
|
November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer
Chantal Quinten, C Kenis, M Hamaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2014
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
H Bonnefoi, W Jacot, M Saghatchian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 13, 2018
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
M Ignatiadis, S Litière, F Rothe, et al.
Gynecologic Oncology
|
October 6, 2020
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study
Jorne Ubachs, Simone N Koole, Max Lahaye, et al.
ESMO Open
|
September 2, 2023
Young oncologists' perspective on the role and future of the clinician-scientist in oncology
K H J Lim, C B Westphalen, A S Berghoff, et al.
Page
of 3